Company Analysis

bioAffinity Technologies, Inc. (BIAF)

Nasdaq: BIAF · Services-Commercial Physical & Biological Research · San Antonio, TX · filing with the SEC since 2017
Grade4.0
◀ Past 3.3● Present 3.8▶ Future 4.5
2 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Report filedMar 16, 2026Mar 31, 2025Apr 1, 2024Mar 31, 2023·
Revenue6,161,9599,362,0222,532,4994,803·
Cost of revenue···467·
Gross profit···4,336·
Research and development1,383,3591,461,2271,467,9361,378,624r1,007,476
Selling, general and administrative9,913,7299,943,4736,790,6542,481,042r1,068,871
Total operating expenses16,734,46718,315,46710,505,7274,015,861r2,206,822
Operating income-10,572,508-8,953,445-7,973,228-4,011,058-2,206,822
Interest expense44,37292,47537,1252,532,6401,001,854
Interest and investment income23,38517,610122,13146,708424
Total non-operating income (expense)-4,293,204-74,73657,210-4,140,596·
Income before income taxes-14,865,712-9,028,181-7,916,018-8,151,654-6,324,463
Income tax expense44,04211,65020,9932,4591,950
Net income including non-controlling interests··8,600,0008,600,000·
Net income-14,909,754-9,039,831-7,937,011-8,154,113-6,326,413
Earnings per share, basic-8.66-22.50r-27.30b-54.30b-70.80b
Earnings per share, diluted-8.66-22.50r-27.30b-54.30b·
Weighted average shares, basic1,721,082404,167r291,584b149,965b89,176b
Weighted average shares, diluted1,721,082404,167r291,584b149,965b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton BIAF · research, not advice